Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 1
1954 1
1989 4
1990 1
1996 1
2004 1
2005 2
2006 2
2007 2
2008 3
2009 1
2010 1
2011 2
2013 1
2020 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
The serine protease HtrA1 is a novel prognostic factor for human mesothelioma.
Baldi A, Mottolese M, Vincenzi B, Campioni M, Mellone P, Di Marino M, di Crescenzo VG, Visca P, Menegozzo S, Spugnini EP, Citro G, Ceribelli A, Mirri A, Chien J, Shridhar V, Ehrmann M, Santini M, Facciolo F. Baldi A, et al. Among authors: mirri a. Pharmacogenomics. 2008 Aug;9(8):1069-77. doi: 10.2217/14622416.9.8.1069. Pharmacogenomics. 2008. PMID: 18681782
PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Zerini D, Jereczek-Fossa BA, Ciabattoni A, Mirri A, Bertoni F, Fersino S, D'Agostino G, Lohr F, Mortellaro G, Triggiani L, Marvaso G, Pepa M, Cuccia F, Alongi F; Italian Association of Radiotherapy, Clinical Oncology (AIRO). Zerini D, et al. Among authors: mirri a. J Cancer Res Clin Oncol. 2020 Sep;146(9):2311-2317. doi: 10.1007/s00432-020-03297-5. Epub 2020 Jun 24. J Cancer Res Clin Oncol. 2020. PMID: 32583236
IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis.
Fastner G, Sedlmayer F, Merz F, Deutschmann H, Reitsamer R, Menzel C, Stierle C, Farmini A, Fischer T, Ciabattoni A, Mirri A, Hager E, Reinartz G, Lemanski C, Orecchia R, Valentini V. Fastner G, et al. Among authors: mirri a. Radiother Oncol. 2013 Aug;108(2):279-86. doi: 10.1016/j.radonc.2013.05.031. Epub 2013 Jul 2. Radiother Oncol. 2013. PMID: 23830467
Tissue heterogeneity in IMRT dose calculation for lung cancer.
Pasciuti K, Iaccarino G, Strigari L, Malatesta T, Benassi M, Di Nallo AM, Mirri A, Pinzi V, Landoni V. Pasciuti K, et al. Among authors: mirri a. Med Dosim. 2011 Summer;36(2):219-27. doi: 10.1016/j.meddos.2010.03.008. Epub 2010 Oct 23. Med Dosim. 2011. PMID: 20970989
23 results